BridgeMD
New treatment option for Anxiety Disorders
Official title Islamic-Oriented vs. Standard Ericksonian Hypnotherapy for Anxiety and Depression
ClinicalTrials.gov ID: NCT06844058
What this study is testing
- What it's testing
- This randomized controlled trial (RCT) aims to compare the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in reducing symptoms of anxiety and depression. The study will enroll 90 participants with mild to moderate anxiety and depression, who will be randomly assigned to one of three groups: (1) IEH intervention, (2) SEH intervention, or (3) control group (no intervention).
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Muslim individuals aged 18-65 years.
- Mild to moderate anxiety and/or depression symptoms (assessed via Beck
- Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI)).
- No formal psychiatric diagnosis but experiencing psychological distress.
- High religious belief levels, assessed via OK-Religious Attitude Scale.
You likely can't join if
- Severe psychiatric disorders (schizophrenia, bipolar disorder, severe MDD).
- Current use of psychotropic medication or undergoing psychotherapy.
- History of substance abuse or dependence.
- Diagnosed dissociative disorders (contraindications for hypnosis).
- Cognitive impairment affecting comprehension of intervention.
- Severe medical conditions that may interfere with participation.
See the full eligibility criteria
- Muslim individuals aged 18-65 years.
- Mild to moderate anxiety and/or depression symptoms (assessed via Beck
- Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI)).
- No formal psychiatric diagnosis but experiencing psychological distress.
- High religious belief levels, assessed via OK-Religious Attitude Scale.
- Not currently receiving psychotherapy or psychotropic medication.
- Ability to give informed consent and complete the study requirements.
- Severe psychiatric disorders (schizophrenia, bipolar disorder, severe MDD).
- Current use of psychotropic medication or undergoing psychotherapy.
- History of substance abuse or dependence.
- Diagnosed dissociative disorders (contraindications for hypnosis).
- Cognitive impairment affecting comprehension of intervention.
- Severe medical conditions that may interfere with participation.
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.